Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2003
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573290 DFMO and celecoxib in combination for cancer chemoprevention and therapy
06/03/2003US6573289 Naphthalene derivatives, their production and use
06/03/2003US6573288 Compounds are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573283 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
06/03/2003US6573280 Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent
06/03/2003US6573277 Metalloproteinase inhibitor
06/03/2003US6573274 Treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle
06/03/2003US6573273 Urea substituted imidazoquinolines
06/03/2003US6573272 Compounds of the formula (I) are disclosed which are FabI inhibitors and are useful in the treatment bacterial infections: which inhibit FabI and are useful for the treatment of bacterial infections.
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573263 For improving perception, concentration power, learning power and/ or memory power
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573257 Salen-metal complexes having superoxide, catalase and/or peroxidase activity to treat or prevent diseases from cell or tissue damage
06/03/2003US6573253 Methods for the administration of amifostine and related compounds
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573243 Pompilid wasp-derived neuropeptides
06/03/2003US6573238 A biodegradable microparticle by forming a coating of a viscous form of a polypeptide e.g., insulin-like growth factor, with a poly(alpha-hydroxy acid), a polyhydroxybutyric acid, a polycaprolactone, a polyorthoester or a polyanhydride
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6572895 Treatment of congestive heart failure
06/03/2003US6572855 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation
06/03/2003US6572854 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
06/03/2003US6572850 Treating obesity by administering a polyether substituted with a pendant B-lactone group;reduction in fat hydrolysis and absorption
06/03/2003US6572638 Method of controlling body temperature while inhibiting thermoregulatory responses
06/03/2003CA2413491A1 Treatment for ischemic stroke
06/03/2003CA2285914C Process and intermediates for a .beta.3-adrenergic receptor agonist
06/03/2003CA2273446C Piperidones
06/03/2003CA2223625C Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044209A1 Novel tetronic acid derivative
05/30/2003WO2003044208A1 Novel tetronic acid dervative
05/30/2003WO2003044196A1 Postsynaptic proteins
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044182A1 CELLS EXPRESSING gob-5 AND USE THEREOF
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044044A1 Novel peptide having angiotensin convertase inhibitory effect
05/30/2003WO2003044024A1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
05/30/2003WO2003044019A1 4-(oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof
05/30/2003WO2003044016A1 3-SUBSTITUTED OXINDOLE β3 AGONISTS
05/30/2003WO2003044014A1 Indole-2-carboxamides as factor xa inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043998A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
05/30/2003WO2003043992A1 4-oxoquinoline derivatives
05/30/2003WO2003043987A2 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043974A2 New pharmaceutical compounds
05/30/2003WO2003043966A2 Clusianon isomers and use thereof
05/30/2003WO2003043663A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/30/2003WO2003043657A1 Topical delivery of codrugs
05/30/2003WO2003043656A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
05/30/2003WO2003043655A1 Remedies for urinary frequency
05/30/2003WO2003043651A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043647A2 A plant extract active as an immunostimulating agent
05/30/2003WO2003043640A2 Treatment of major depressive disorder using glucocorticoid receptor antagonists
05/30/2003WO2003043636A1 Nicotin-or isonicotin benzothiazole derivatives
05/30/2003WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003043626A1 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043622A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
05/30/2003WO2003043619A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2003043591A1 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation
05/30/2003WO2003043581A2 Composition and method for modulating bar/fxr receptor activity
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003043571A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
05/30/2003WO2003028697A3 Liposome loading with metal ions
05/30/2003WO2003020104A3 Method of treating systemic inflammatory response syndrome
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2003002106A3 Use of tyrosine kinase inhibitions for treating allergic diseases
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002064132A3 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
05/30/2003WO2002062795A3 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
05/30/2003WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis
05/30/2003WO2002051415B1 Use of sequestrants for treating prion diseases
1 ... 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 ... 1564